Ginger

Metadata

Approved Indications

Commission E (Germany)

• Approved for dyspeptic complaints
• Approved for prevention of motion sickness
• Does NOT approve use in pregnancy-related nausea

ESCOP

• Prevention of motion sickness (nausea and vomiting)
• Post-operative nausea and vomiting (prevention)
• Does NOT endorse pregnancy-related nausea

EMA/HMPC

• Well-established use: Prevention of nausea and vomiting in motion sickness (adults)
  • This is the highest classification, indicating bibliographic evidence of effectiveness and safety covering at least 10 years in the EU
• Traditional use: Symptomatic treatment of mild complaints affecting the stomach or gut (bloating, flatulence) — adults
• Traditional use: Symptomatic treatment of motion sickness — adults and children aged 6+

British Herbal Compendium

• Includes use for pregnancy-related nausea (more permissive than German/ESCOP position)

Agreement/Disagreement Analysis

Strong agreement on motion sickness across all bodies. The major disagreement is on pregnancy nausea: the British Herbal Compendium permits it, numerous clinical trials support it, and WHO acknowledges it, but Commission E and ESCOP remain cautious and do not endorse. EMA does not specifically address pregnancy nausea in the monograph. This reflects a conservative European precautionary approach to herbal use in pregnancy.

Conditions Treated

Approved/Monographed

• Motion sickness (nausea and vomiting prevention)
• Dyspepsia, bloating, flatulence
• Post-operative nausea and vomiting (ESCOP)

Widely Used but Cautiously Regulated

• Pregnancy-related nausea and vomiting (NVP / morning sickness) — positive clinical evidence but regulatory caution in Germany/ESCOP

Other Researched Uses

• Chemotherapy-induced nausea and vomiting (CINV)
• Dysmenorrhea (menstrual pain)
• Osteoarthritis pain
• Migraine (acute treatment; adjunctive)

Mechanism of Action

Key Active Compounds

• Gingerols (6-gingerol, 8-gingerol, 10-gingerol): Primary pungent compounds in fresh ginger
  • 6-Gingerol: most abundant and most studied
• Shogaols (6-shogaol, etc.): Formed from gingerols during drying/cooking; more potent
• Zingerone: Formed by cooking; less pungent
• Essential oil (1-3%): Zingiberene, bisabolene, neral, geranial

Anti-Emetic Mechanisms

• 5-HT3 receptor antagonism: Ginger compounds act as antagonists at the 5-HT3 (serotonin) receptor in the GI tract and chemoreceptor trigger zone — the same target as ondansetron (Zofran)
• Cholinergic (muscarinic) receptor antagonism: May reduce vestibular-mediated nausea (motion sickness)
• NK1 receptor effects: Some evidence for substance P/NK1 pathway modulation
• Prokinetic activity: Enhances gastric motility and accelerates gastric emptying

Anti-Inflammatory Mechanisms

• COX-1 and COX-2 inhibition
• Lipoxygenase (5-LOX) inhibition
• NF-kB modulation
• These underpin the dyspepsia and OA applications

Carminative Effects

• Relaxation of lower esophageal sphincter
• Promotion of GI motility
• Reduction of intestinal gas formation

Clinical Evidence Summary

Motion Sickness

• Multiple positive RCTs and systematic reviews
• EMA classification as “well-established use” reflects strong evidence
• 1000 mg ginger powder 1 hour before travel is the standard protocol
• Effectiveness demonstrated as superior to placebo and comparable to other motion sickness remedies (dimenhydrinate)

Pregnancy-Related Nausea and Vomiting

• Meta-analysis (13 studies): Ginger significantly improved general NVP symptoms and reduced severity of nausea vs. placebo, but was not significant for reducing vomiting alone
• Systematic review (11 trials, 2,630 subjects): Dried ginger powder resulted in significant improvement in NVP
• Comparison with vitamin B6: Meta-analysis found ginger comparable to vitamin B6 for NVP relief
• Typical effective dose: 1 g/day (divided into 250 mg 4 times daily or 500 mg twice daily) for 3-5 days
• Adverse events: 3.3% of 777 patients reported mild side effects (mild GI symptoms, sleepiness)
• Limitation: most trials were short-term (3-7 days)

Post-Operative Nausea and Vomiting (PONV)

• Meta-analysis: Ginger was significantly more effective than placebo in reducing the frequency of vomiting and intensity of nausea
• Dose: 1000 mg for 1 hour before anesthesia induction
• Comparable to some conventional antiemetics in some studies
• [UNCERTAIN] Some meta-analyses show positive results, others are equivocal

Chemotherapy-Induced Nausea

• Mixed results; some positive trials when used as adjunct to 5-HT3 antagonists
• Not consistently superior to placebo as monotherapy
• [NEEDS-RESEARCH] Optimal dosing and timing for CINV still unclear

Dyspepsia

• Commission E approved based on traditional evidence
• Modern trials suggest ginger accelerates gastric emptying
• Limited high-quality RCT data specifically for dyspepsia as primary endpoint

European vs. US/Anglophone Consensus

The pregnancy nausea divergence is significant: where US/Anglophone practice readily recommends ginger for morning sickness (ACOG guidelines), European regulatory bodies remain more cautious despite positive clinical evidence.

Safety Profile

Contraindications

• Gallstones: Ginger may increase bile secretion (cholagogue effect) — use with caution or avoid
• Pregnancy (doses >1 g/day): Higher doses not recommended; limited safety data at higher doses
• Close to labor: Some sources contraindicate ginger near term due to theoretical bleeding risk
• History of miscarriage or vaginal bleeding: Based on limited evidence; precautionary

Drug Interactions

• Anticoagulants/Antiplatelets (warfarin, aspirin, heparin): Theoretical antiplatelet activity; clinical significance at dietary doses is doubtful, but supplemental doses may warrant monitoring
• Antidiabetic agents: May have additive hypoglycemic effect; monitor blood glucose
• Antihypertensives: Possible additive hypotensive effect (weak evidence)
• P-glycoprotein substrates: Some in vitro evidence for P-gp inhibition; clinical relevance unclear

Side Effects

• Common (mild): Heartburn, mild GI irritation (especially at doses >6 g/day)
• Uncommon: Diarrhea, oral irritation, reflux
• Rare: Allergic reactions (dermatitis)
• Dose-dependent: Doses >6 g may cause significant gastric irritation

Pregnancy/Lactation

• Pregnancy: Considered likely safe at doses up to 1 g/day based on clinical trial data
  • No increase in malformation rates, stillbirth, or preterm birth reported in trials
  • EMA does not specifically approve but does not contraindicate at standard doses
  • Commission E: does not recommend in pregnancy (conservative position)
  • Avoid close to labor or in women with bleeding disorders or history of miscarriage
• Lactation: Insufficient data; generally considered compatible with breastfeeding at dietary doses

Clinical Dosage

Motion Sickness (EMA Well-Established Use)

• Adults: 1000 mg powdered ginger rhizome, taken 30-60 minutes before travel
• Can repeat doses of 500 mg every 4 hours if needed (max ~4 g/day)
• Children 6+ (Traditional use): appropriate dose reduction

Pregnancy Nausea (Research Doses — Not Formally Approved in EU)

• Standard protocol: 250 mg 4 times daily (1 g/day total)
• Or: 500 mg twice daily
• Duration: 3-5 days in most studies (some up to 3 weeks)
• Do not exceed 1 g/day during pregnancy

Post-Operative Nausea (ESCOP)

• 1000 mg powdered ginger 1 hour before anesthesia induction
• Some protocols add 500 mg 2 hours before surgery

Dyspepsia (Traditional Use)

• Powdered rhizome: 0.5-1 g, 2-3 times daily
• Tincture (1:5): 1.5-3 mL daily
• Tea: 0.5-1 g dried rhizome per cup, 2-3 cups daily

Key Products (European Market)

• Zintona (standardized ginger capsules) — one of the most studied products in motion sickness
• Various ginger rhizome capsules (traditional use registered)
• Ginger tea preparations

Sources

• EMA/HMPC Assessment Report on Zingiber officinale Roscoe, rhizoma (Final, Revision 1)
• EMA/HMPC European Union Herbal Monograph on Zingiberis rhizoma
• Commission E Monograph: Zingiberis rhizoma (Bundesanzeiger)
• ESCOP Monograph: Zingiberis rhizoma
• Viljoen et al. (2014) “A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting” PMC3995184
• Ding et al. (2013) “The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review” PMID: 22951628
• Ernst & Pittler (2000) “Efficacy of ginger for nausea and vomiting: a systematic review” Br J Anaesth PMID: 10793599
• Tiran (2012) “Ginger for nausea and vomiting of pregnancy” PMC4755634
• Chaiyakunapruk et al. (2006) “Ginger for prevention of PONV” Am J Obstet Gynecol
• NCCIH: Ginger (nccih.nih.gov)

Connections

• Turmeric Curcumin: Same plant family (Zingiberaceae); overlapping anti-inflammatory mechanisms
• Black Pepper Piperine: Sometimes combined with ginger in traditional medicine (Trikatu formula)
• Butterbur: Both address headache-adjacent conditions
• GI herbs module: Ginger’s dyspepsia indication overlaps with peppermint, artichoke, caraway
• Licorice: Both have GI protective properties through different mechanisms